ALKBH5 and cancer: Here, we show that shRNA-mediated depletion of ALKBH5 or FTO (using a lentiviral system) significantly decreased ATF4 protein levels in SOR-treated Hep3B cancer cells (Figure 1B,C and Supplementary Figure S1).